Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals.
Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals.
复制标题
DOI:
10.3109/00952990.2014.945590
复制
发表时间:
2015-03
期刊:
影响因子:
--
通讯作者:
McRae-Clark A
中科院分区:
文献类型:
--
作者:
Moran-Santa Maria MM;Baker NL;Ramakrishnan V;Brady KT;McRae-Clark A
Stress and drug-paired cues increase drug craving and noradrenergic activity in cocaine-dependent individuals, thus medications that attenuate noradrenergic activity may be effective therapeutic treatment options for cocaine-dependent individuals. To examine the impact of acute administration of the α-2 adrenergic receptor agonist guanfacine on responses to multiple risk factors for relapse in cocaine-dependent individuals. In a double-blind, placebo-controlled study, cocaine-dependent individuals (N=84), were randomized to receive either 2 mg guanfacine (n=50) or placebo (n=34). Within each treatment arm, subjects were randomized to either a stress (guanfacine n=26; placebo n=15) or a no-stress (guanfacine n=24; placebo n=19) group. Participants in the stress group performed the Trier Social Stress Test. Subjects in each group were exposed to a neutral cue and then to cocaine-related cues. Plasma cortisol and subjective responses were compared between the four groups. The no-stress guanfacine group reported greater craving in response to cocaine-cues as compared to the neutral cue (p<0.001). The guanfacine stress group reported greater subjective stress at the neutral cue than at baseline (p=0.032). The cocaine-cue increased subjective stress in the guanfacine (p<0.001) no-stress group. There were no effects of guanfacine on cortisol levels in either the stress or no stress groups (all p>0.70). This study found no effects of a single 2 mg dose of guanfacine on reactivity to stress and cues alone or on the interaction of stress and drug cues. In cocaine-dependent individuals an acute 2 mg dose of guanfacine may not be an effective therapeutic treatment strategy.
登录
查看更多内容
影响因子:
2.7
作者:
Feltenstein, Matthew W.;See, Ronald E.
通讯作者:
See, Ronald E.
影响因子:
3.2
作者:
KIRSCHBAUM, C;PIRKE, KM;HELLHAMMER, DH
通讯作者:
HELLHAMMER, DH
影响因子:
3.4
作者:
Erb, S;Shaham, Y;Stewart, J
通讯作者:
Stewart, J
影响因子:
4.2
作者:
Aharonovich, E;Hasin, DS;Nunes, EV
通讯作者:
Nunes, EV
影响因子:
7.6
作者:
Jäkälä, P;Riekkinen, M;Riekkinen, P
通讯作者:
Riekkinen, P